ANGO

AngioDynamicsD

Nasdaq / Health Care Equipment & Services

Quote time unavailable

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

earnings

Source

External coverage

Decided

2026-10-01

AngioDynamics Tops Revenue Forecasts and Raises Sales Outlook for Fiscal 2027 (ANGO)

AngioDynamics topped revenue forecasts and raised its FY2027 sales outlook, a positive issuer-specific signal. The company’s July 14 release reported FY2026 Q4 net sales of $86.6 million and FY2027 net sales guidance of $336–341 million ([AngioDynamics investor release](https://investors.angiodynamics.com/news-releases/news-release-details/angiodynamics-reports-record-fiscal-year-2026-fourth-quarter-and)).

View event details4 more curated

Sentiment decomposition

-26.0

30-day score

Company-55%

Macro-26.030%

Pulse-15%

Weekly research-10-day

Company, Macro, and Pulse form the existing 30-day artifact blend. Weekly research is tracked separately for 10 days and can contribute at most 10% of the sentiment pillar when live mode is enabled.